A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulation. [PDF]
Catak MC +17 more
europepmc +1 more source
Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial. [PDF]
Sanmarti R +38 more
europepmc +1 more source
Effect of immunosuppressive drugs on glucose-stimulated insulin secretion: concentration-response studies in dynamic perifusion assays. [PDF]
Chuang ST +3 more
europepmc +1 more source
Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders. [PDF]
Wang C +6 more
europepmc +1 more source
Early-onset type 1 diabetes mellitus in a child with a pathogenic <i>CTLA4</i> variant complicated by generalized lipodystrophy and severe insulin resistance: a case report and literature review. [PDF]
Ding Y +8 more
europepmc +1 more source
Boosting donor chimerism after sickle cell transplants. [PDF]
Laditan MM +8 more
europepmc +1 more source
Cancer risk associated with abatacept among older individuals with rheumatoid arthritis in the United States. [PDF]
Ahmed S, Mariette X, Seror R, Engels EA.
europepmc +1 more source
Persistence, switching, and discontinuation patterns of b/tsDMARDs in patients with rheumatoid arthritis: a single-center retrospective cohort study from Saudi Arabia. [PDF]
Aldosari SA +4 more
europepmc +1 more source
Successful Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis, Myositis, and Myasthenia Overlap Syndrome With Baricitinib and Abatacept. [PDF]
Alnahas Z +3 more
europepmc +1 more source
With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete? [PDF]
Syrimi Z +4 more
europepmc +1 more source

